Zhang Xiaochen, McClean Daniel, Ko Emily, Morgan Mark A, Schmitz Kathryn
Penn State University.
University of Pennsylvania.
Oncol Nurs Forum. 2017 May 1;44(3):366-374. doi: 10.1188/17.ONF.366-374.
PURPOSE/OBJECTIVES: To establish the feasibility and acceptability of completing a higher dose of the planned physical activity volume among women with ovarian cancer, including those undergoing active treatment. .
DESIGN: A pre-/post-test exercise intervention. All participants were asked to complete 225 minutes per week of physical activity for 26 weeks. Multiple supports were provided, including exercise DVDs, self-reported logs, and an objective physical activity tracker (Fitbit®). .
SETTING: Home-based exercise intervention with in-person training and telephone follow-ups. .
SAMPLE: 10 women with ovarian cancer who were treated within Penn Medicine in Philadelphia, Pennsylvania. .
METHODS: Home-based, in-person exercise counseling was provided by an exercise trainer weekly for the first six weeks and then monthly for a total of 26 weeks. Weekly follow-up telephone calls were used to assess exercise adherence and barriers to completing exercise, review symptom changes, and provide behavioral support. .
MAIN RESEARCH VARIABLES: Feasibility and acceptability. .
FINDINGS: Eight participants completed the study and achieved at least 80% of the prescribed exercise dose. Five participants were undergoing chemotherapy simultaneously. Participants experienced no adverse events during the 26-week intervention. Compared to baseline, average steps increased by 1,593 per day and moderate-intensity physical activity increased by 15 minutes per day. .
CONCLUSIONS: A 225-minutes-per-week exercise program is feasible and acceptable in a population of patients with ovarian cancer. Participants significantly improved their physical activity during the 26-week intervention. .
The findings suggest that nursing professionals could recommend that women with ovarian cancer exercise 225 minutes per week regardless of cancer and/or treatment trajectory. For those experiencing aches and pains, behavioral supports and suggestions of a lower exercise dose are needed to maintain physical activity.
目的/目标：确定卵巢癌女性，包括正在接受积极治疗的患者，完成更高剂量计划体力活动量的可行性和可接受性。
一项前后测试的运动干预。所有参与者被要求在26周内每周完成225分钟的体力活动。提供了多种支持，包括运动DVD、自我报告日志和客观的体力活动追踪器（Fitbit®）。
基于家庭的运动干预，包括面对面培训和电话随访。
10名在宾夕法尼亚州费城的宾夕法尼亚大学医学中心接受治疗的卵巢癌女性。
由一名运动教练在前六周每周提供一次基于家庭的面对面运动咨询，之后每月一次，共26周。每周进行随访电话，以评估运动依从性和完成运动的障碍，审查症状变化，并提供行为支持。
可行性和可接受性。
8名参与者完成了研究，并达到了规定运动剂量的至少80%。5名参与者同时正在接受化疗。参与者在26周的干预期间未经历不良事件。与基线相比，平均每天步数增加了1593步，中等强度体力活动增加了15分钟。
每周225分钟的运动计划在卵巢癌患者群体中是可行且可接受的。参与者在26周的干预期间显著改善了他们的体力活动。
研究结果表明，护理专业人员可以建议卵巢癌女性无论癌症和/或治疗轨迹如何，每周进行225分钟的运动。对于那些经历疼痛的患者，需要行为支持和较低运动剂量的建议来维持体力活动。
